1. Gold WM. Murray JF, Nadel JA, editors. Pulmonary function testing. Textbook of respiratory medicine. 2005. 4th ed. Philadelphia: Saunders;671–733.
2. Oh YM, Hong SB, Shim TS, Lim CM, Koh YS, Kim WS, et al. Effect of a new spirometric reference equation on the interpretation of spirometric patterns and disease severity. Tuberc Respir Dis. 2006. 60:215–220.
3. Standards for the diagnosis and management of patients with COPD [Internet]. Version 1.2. American Thoracic Society/European Respiratory Society Task Force. 2004. updated 2005 September 8. New York: American Thoracic Society;Available from:
http://www.thoracic.org/copd/.
4. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med. 2001. 163:1256–1276.
5. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991. 144:1202–1218.
6. Celli BR, Halbert RJ, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J. 2003. 22:268–273.
7. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005. 26:948–968.
8. American Thoracic Society. Standardization of Spirometry, 1994 update. Am J Respir Crit Care Med. 1995. 152:1107–1136.
9. Choi JK, Paek DM, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis. 2005. 58:230–242.
10. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Official Statement of the European Respiratory Society. Lung volumes and forced ventilatory flows: report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Eur Respir J Suppl. 1993. 16:5–40.
11. Song EH, Oh YM, Hong SB, Shim TS, Lim CM, Lee SD, et al. Selection of reference equations in lung volumes and in diffusing capacity. (Unpublished).
12. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999. 159:179–187.
13. Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J. 2002. 20:1117–1122.
14. Brusasco V, Pellegrino R, Rodarte JR. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. Eur Respir J. 1997. 10:1316–1320.
15. Hyatt RE, Okeson GC, Radarte JR. Influence of expiratory flow limitation on the pattern of lung emptying in normal man. J Appl Physiol. 1973. 35:411–419.
16. Rodarte JR, Hyatt RE, Cortese DA. Influence of expiratory flow on closing capacity at low expiratory flow rates. J Appl Physiol. 1975. 39:60–65.
17. Olive JT Jr, Hyatt RE. Maximal expiratory flow and total respiratory resistance during induced bronchoconstriction in asthmatic subjects. Am Rev Respir Dis. 1972. 106:366–376.
18. Guerry-Force ML, Muller NL, Wright JL, Wiggs B, Coppin C, Pare PD, et al. A comparison of bron chiolitis obliterans with organizing pneumonia, usual interstitial pneumonia, and small airways disease. Am Rev Respir Dis. 1987. 135:705–712.
19. Macklem PT, Thurlbeck WM, Fraser RG. Chronic obstructive disease of small airways. Ann Intern Med. 1971. 74:167–177.